University of California, San Diego researchers have developed a new injectable hydrogel that could be an effective and safe treatment for tissue damage caused by heart attacks. The study by Karen Christman and colleagues appears in the Feb. 21 issue of the Journal of the American College of Cardiology … Read the full story from the UCSD Newsroom
FDA-approved non-surgical technology alters heart tissue that triggers atrial fibrillation
UC San Diego Sulpizio Cardiovascular Center is now offering patients with atrial fibrillation the breakthrough benefits of heat energy, or radio frequency waves, to irreversibly alter heart tissue that triggers an abnormal heart rhythm or arrhythmia. The THERMOCOOL® SF Catheter is an FDA-approved outpatient procedure for an early-stage form of the condition called paroxysmal atrial fibrillation, when recurring symptoms are unresponsive to medicine. … Read the full story from the UC San Diego Health System Newsroom
In the latest of a series of related papers, researchers at the University of California, San Diego School of Medicine, with colleagues in Austria and elsewhere, present a new and more definitive explanation of how fibrotic cells form, multiply and eventually destroy the human liver, resulting in cirrhosis… Read the full story from the UCSD Newsroom
Pictured above is David Brenner, MD, Vice Chancellor for Health Sciences and dean of the UC San Diego School of Medicine, who is senior author of the research report. First author of the study is Dr. Christoph H. Österreicher of the Biomedical Genomics (BIOGEM) Microarray Facility in the UCSD Department of Medicine, the Laboratory of Gene Regulation and Signal Transduction in the UCSD Department of Pharmacology, and the Medical University of Vienna. Other Department of Medicine coauthors are Drs. Melitta Penz-Österreicher (Medical University of Vienna), Roman Šášik, and BIOGEM director Dr. Gary Hardiman.
Dr. Martina Buck, faculty researcher in the Division of Gastroenterology, has developed the first tissue culture system for the Hepatitis C virus. The system offers a model in which investigators can more easily test potential treatments for Hepatitis C.
Her report of the system is published in PLoS ONE.
Citation for the report: Buck M (2008) Direct Infection and Replication of Naturally Occurring Hepatitis C Virus Genotypes 1, 2, 3 and 4 in Normal Human Hepatocyte Cultures. PLoS ONE 3(7): e2660. doi:10.1371/journal.pone.0002660 | Read the report (free full text)